Abstract Key fragments of the cytotoxic marine macrolide mirabalin have been synthesized, by using a flexible strategy based on asymmetric reductions to control the hydroxy-and carbamate-bearing stereocenters. In particular, ruthenium or rhodium-mediated asymmetric hydrogenation and transfer hydrogenation were used in combination with a dynamic kinetic resolution to control two contiguous stereocenters in a single step.
Introduction
Lithistid demosponges are an assemblage of sponges predominantly found in deeper waters. 1, 2 They are regarded as an excellent source of structurally diverse and bioactive secondary metabolites. [3] [4] [5] In particular, numerous novel macrolides have been isolated from the Theonellidae family exhibiting excellent biological activities. [6] [7] Among them, mirabalin, a macrocycle, has been extracted from Siliquariaspongia mirabilis, a lithistid demosponge collected from the archipelago of Chuuk, Micronesia (Figure 1 ). 8, 9 This macrocycle exhibits potent cytotoxicity toward human colon tumor cell line HCT-116 with an IC50 of 0.27 µM. Morever, it has been found that the macrocycle ring is crucial to mirabalin antitumor activity. Indeed, no inhibition of the tumor cells growth was observed when treated with the linear polyketide side-chain. From a structural point of view, mirabalin exhibits a 35-membered macrocyclic lactam-lactone possessing a fully conjugated pentaene system along with a tetrasubstituted tetrahydropyran ring. In addition, a linear polyketide side-chain is linked to the macrocyclic ring with an amide linkage. An investigation combining advanced NMR and MS techniques allowed the partial elucidation of the structure of mirabalin. Undeniably, because of the large number of stereocenters and the low amount of material available, the absolute configurations of 12 out of the 25 stereocenters could not be assigned. Nevertheless, the geometry for each of the double bonds was established unambiguously (Figure 1 ).
Figure 1.
Picture of Siliquariaspongia mirabilis and the structure of mirabalin (1) 9 .
As part of our ongoing studies on the total synthesis of natural products, [10] [11] [12] [13] [14] [15] [16] [17] and intrigued by the structural intricacy of this macrolide, we embarked on a study aiming at developing a flexible, convergent and modular route to one isomer of mirabalin where the configurations of the twelve unknown stereocenters were arbitrarily fixed (Scheme 1). Recently, we reported a synthetic strategy toward the C44−C65 polyketide side chain 18 and toward the C14−C29 fragment of mirabalin, 19 as well as a straightforward method to construct the pentaene moiety C4-C14. 20 Scheme 1 shows the mirabalin global retrosynthetic plan with late stage esterification, peptide coupling and C=C bond formation to access the macrocycle by macrolactamization, suggesting A and B as suitable key intermediates for the sake of convergence. Herein, we report a flexible synthesis of fragments A and B but also details about the synthesis of isomers of the C44−C65 side chain of mirabalin.
Results and Discussion

Synthesis of fragment A
Our retrosynthetic analysis was based on known methods for the introduction of the phenyltetrazolyl sulfone moiety by a hydroboration/Mitsunobu/oxidation sequence applied to alkene 2. We therefore envisaged that the aldehyde 3 represented a useful intermediate in the synthesis of the unsaturated compound 2, and aldehyde 3 could be obtained from α-amino β-ketoester 4 after asymmetric hydrogenation [21] [22] [23] via a dynamic kinetic resolution, [24] [25] [26] Claisen condensation and asymmetric hydrogenation (Scheme 3). 27 Our synthesis began with the preparation of the hydrochloride ammonium salt 4 in two steps from methyl acetoacetate 5 after nitrosation followed by hydrogenolysis of the oxime 6 under acidic conditions. To control the anti configuration at C66 and C42, a ruthenium-catalyzed asymmetric hydrogenation through dynamic kinetic resolution of the racemic α-amino β-keto ester hydrochloride 4 was envisaged. Using this method, the corresponding anti-aminoalcohol was successfully prepared with 90% diastereomeric excess and 91% enantiomeric excess. The reaction was performed in CH2Cl2/MeOH (10:1) at 50 o C under 13 bar of H2 using 2 mol% of the in situ prepared [Ru((R)-Synphos)]Br2] catalyst 30 (Scheme 3) . Protection of the amino group as a carbamate and conversion of the hydroxy function into a TBS ether delivered compound 8. The ensuing fully protected amino hydroxy ester 8 was then submitted to a Claisen condensation with tert-butyl acetate under basic conditions to deliver β-keto ester 9 in 87% yield (Scheme 3). Scheme 3. Preparation of b-keto ester 9.
We then turned our attention to the asymmetric hydrogenation of ketone 9 (Scheme 4). Different conditions varying catalyst loading and hydrogen pressure were screened using the binuclear complex [{RuCl((S)-Synphos)}2(μ-Cl)3][Me2NH2] 30 in EtOH at 50 o C. No influence of the catalyst loading was observed on the stereochemical outcome of the reaction. However, changing the hydrogen pressure from 70 to 100 bar afforded a better result in terms of diastereoselectivity (dr switching from 74:26 to >99:1). With these optimized conditions in hand, the synthesis was pursued with the protection of aminoalcohol 10 to the oxazolidine 11. It was found that the starting material 10 was not fully converted during the reaction and the acidic conditions led to the cleavage of the TBS group on both compounds 10 and 11. The yield was modest and variable despite several experimentations. Nevertheless, compound 11 was converted to aldehyde 3 with Dibal-H in 77% yield. Addition of vinylmagnesium bromide to aldehyde 3 at low temperature provided the desired allylic alcohol 12 in 77% yield with a diastereoselectivity of 62:38. The two stereoisomers were separated by flash column chromatography and the synthesis of compound A' was carried out with the major diastereomer, the absolute configuration of which was determined by Mosher analysis (Scheme 4). 31 After protection of alcohol 12 (TBSCl, imid, DMF, rt), hydroboration/oxidation of the obtained compound 2 furnished the desired product 13 in 75% yield. Formation of thioether 14 was accomplished using a Mitsunobu reaction 32,33 applied to alcohol 13 (1-phenyl-1H-tetrazole-5-thiol, DIAD, PPh3, THF, rt) and the thioether 14 was converted to the corresponding sulfone in 68% yield by oxidation with m-CPBA (Scheme 5). Thus, compound A' was obtained in 14 steps in 1.1% overall yield from methyl acetoacetate 5 and three contiguous stereocenters were controlled using asymmetric hydrogenation. To appreciate the feasibility of our envisaged retrosynthetic plan, we performed a Julia-Kocienski olefination 34 between compound A' and the aldehyde generated from alcohol 15 35 (corresponding to the C25-C28 fragment of the macrocycle, Scheme 1). Pleasingly, the desired E-alkene was obtained in 76% yield with tight control of the double bond geometry (E/Z > 95:5) (Scheme 5). The synthesis of the α-carbamate β-ketoester 17 proceeded as shown in Scheme 7. After PMBmonoprotection of ethane-1,2-diol 20 and Dess-Martin oxidation of the obtained 21, aldehyde 18 was isolated in 61% yield. The other partner 19 was prepared by simple N-Boc protection of glycine methyl ester hydrochloride 22 in 97% yield. Thereafter, reaction of the zinc derivative of 19 with aldehyde 18 furnished the corresponding α-carbamate β-hydroxy ester whose oxidation afforded the desired β-keto ester 17. It is noteworthy that, after thorough investigation, only the use of Dess-Martin periodinane in the absence of NaHCO3 allowed the oxidation, albeit in low yield; other attempts using IBX, Parikh-Doering, Ley-Griffith, Swern, Fétizon or pyridinium dichromate reagents led only to degradation products. With the desired keto ester 17 in hand, we focused on the asymmetric reduction of 17 via dynamic kinetic resolution.
O
After careful optimization of the reaction parameters, compound syn-23 was obtained in 73% yield with good diastereomeric ratio (dr = 86:14) and enantioselectivity (er = 90:10) by using 0.5 mol% of the complex [RuBr2((S)-Synphos)] prepared in situ from [Ru(COD)(2-methylallyl)2], 30 under 50 bar of hydrogen pressure at 50 o C in dichloromethane. Subsequent TBS protection of the hydroxyl gave syn-24 and the desired compound syn-B' was finally obtained by hydrolysis of the methyl ester to the corresponding carboxylic acid (Scheme 7).
Scheme 7. Synthesis of compound syn-B' through asymmetric hydrogenation.
To obtain the anti-isomer of fragment B, we turned our attention to the use of asymmetric transfer hydrogenation of 17 in combination with dynamic kinetic resolution. Preliminary screening employing different catalysts Cat I, 41 Cat II, 42 and Cat III 43, 44 with HCOOH/Et3N (5:2) as the hydrogen donor demonstrated that faster reaction times as well as better diastereoselectivities in favor of compound anti- 23 mol% without any loss of stereoselectivity and compound 23 was isolated with a comparable 70% yield. It is noteworthy that at this point of the synthesis inseparable mixtures of synand anti-isomers were obtained. To complete the synthesis of fragment B, the newly formed hydroxy-ester 23 was protected by using TBSCl and imidazole in 51% yield before hydrolysis of the ester with TMSOK yielded the fully protected compound anti-B'. Gratifyingly, flash chromatography allowed separation of the synand anti-isomers (Scheme 8).
Scheme 8. Synthesis of compound anti-B' through asymmetric transfer hydrogenation.
Thus, compound anti-B' was synthesized in 7 steps starting from ethylene glycol 20 in 2.2% overall yield. This strategy inherently makes the synthesis flexible because all the four stereoisomers of fragment B can be synthesized by simply changing the configuration of the chiral ligand and by moving from asymmetric hydrogenation to asymmetric transfer hydrogenation.
Synthesis of stereoisomers of the C44−C65 side chain
As outlined above, flexibility of our synthetic plan was essential as the configurations of several stereogenic centers remain unknown. We decided to prepare other isomers of the north fragment of the targeted molecule (C44-C65 fragment, the two relevant stereocenters are highlighted with a star on Scheme 9). As such, it was shown previously that the C44-C65 part of the molecule could easily be synthesized after assembly of fragments C1, C2 and C3 (Scheme 9). 18 Herein, we focused our attention to the modifications of the two C46 and C49 stereocenters of fragment C3. The stereogenic center at C46 would be easily modulated by simply changing the configuration of the upstream Roche ester, while modification of the configuration at the C49 stereocenter would be achieved by switching the ligand configuration during the asymmetric hydrogenation, thus allowing access to new isomers of the side chain. The synthesis began with the benzyl protection of (R)-Roche ester 25 followed by reduction of the resulting ester 26 to 27 using LiAlH4. Garegg iodination 45 (I2, PPh3, imid, CH2Cl2, rt) of the latter afforded iodide 28, which was used for the alkylation of methyl acetoacetate 46 In summary, the facile synthesis of two new isomers 35 and 36 of the C44-C65 part of mirabalin demonstrated the high flexibility of the synthetic plan offered by using asymmetric reduction and one can envisage to access other stereoisomers using this versatile reduction. 
Conclusions
In conclusion, the synthesis of several key fragments of mirabalin 1 was achieved using flexible and robust methods based on asymmetric hydrogenation and transfer hydrogenation. The C30-C67 fragment (compound A') as well as two isomers of the C1-C36 subunits (compounds syn-B' and anti-B') have been prepared. Moreover the synthesis of two isomers of the C44-C65 part of mirabalin has been achieved. Most importantly, the flexibility of this approach provides a platform for modification of several unknown stereocenters. The assembly of the different fragments is currently being pursued in our laboratory.
Experimental Section
General. All air and/or water sensitive reactions were carried out under an argon atmosphere. Enantiomeric excesses were determined by HPLC using a chiral stationary phase column (Chiralpak IA) and eluting with a hexane/isopropanol mixture as indicated.
Methyl (Z)-2-(hydroxyimino)-3-oxobutanoate (6) . A solution of methyl acetoacetate 5 (15 g, 129 mmol, 1 equiv) in acetic acid (100 mL) was cooled to 0 o C and a suspension of NaNO2 (22.3 g, 323 mmol, 2.5 equiv) in water (75 mL) was added dropwise, the temperature of the reaction mixture being kept below 5 o C. After evolution of the brown fumes, the stirring was maintained 1.5 h at 0 o C and then at rt until completion of the reaction, monitored by TLC (1 h). The reaction mixture was then diluted and extracted with Et2O. The combined organic layers were washed with saturated aqueous NaHCO3, dried over MgSO4, concentrated under reduced pressure and the crude mixture was purified by silica gel column chromatography (cyclohexane/EtOAc: 6/4) to give the desired product 6 (9.54 g, 51%) as a white solid. mp (7) . (R)-Synphos (377 mg, 0.59 mmol, 0.022 equiv) and [Ru(COD)(η 3 -2-methylallyl)2] (171 mg, 0.54 mmol, 0.02 equiv) were placed in a reaction tube and the vessel was purged with argon. Anhydrous acetone (20 mL) previously degassed by three vacuumargon cycles was added at rt. To this suspension was added dropwise methanolic HBr (6.6 mL, 0.044 equiv of a 0.18N solution prepared by adding 48% aqueous HBr in degassed methanol) and the suspension was stirred at room temperature for 30 min. The suspension immediately turned yellow, then an orange precipitate appeared and the solvent was thoroughly evaporated under vacuum to give the catalyst as an orange-brown solid [RuBr2((R)-Synphos)], which was used directly. The β-keto ester hydrochloride 4 (4.5 g, 26.9 mmol, 1 equiv) was then added followed by previously degassed anhydrous CH2Cl2 (20 mL) and degassed alcoholic solvent MeOH (2 mL). The reaction vessel was degassed by three vacuum-argon cycles and then placed under argon in a 250 mL stainless steel autoclave. The argon atmosphere was replaced with hydrogen by three cycles of pressurizing and the pressure adjusted to 13 bar. The autoclave was heated at 50 o C and stirring was maintained for 23 h. After cooling, the reaction mixture was concentrated under reduced pressure to afford the crude β-hydroxy ester. It was then dissolved in degassed MeOH (50 mL) and NaHCO3 ( (8) . To a solution of 7 (7.23 g, 31 mmol, 1 equiv) in dry DMF (28 mL) were added successively imidazole (0.876 g, 12.87 mmol, 3 equiv) and TBSCl (1.62 g, 10.73 mmol, 2.5 equiv) at rt. The mixture was stirred for 23 h at rt, then brine and Et2O were added. The aqueous phase was extracted with Et2O. The combined organic layers were washed with brine, dried over MgSO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2, petroleum ether/EtOAc: 96/4) to give 8 ( 
Methyl (2R,3R)-2-[(tert-butoxycarbonyl)amino]-3-hydroxybutanoate
Methyl (2R,3R)-2-[(tert-butoxycarbonyl)amino]-3-[(tert-butyldimethylsilyl)oxy]butanoate
tert-Butyl (4R,5R)-4-[(tert-butoxycarbonyl)amino]-5-[(tert-butyldimethylsilyl)oxy]-3-oxohexanoate (9)
To a solution of diisopropylamine (14.1 mL, 100.4 mmol, 3.6 equiv) in dry THF (175 mL) was added nbutyllithium (49 mL, 97.7 mmol, 2M, 3.5 equiv) at 0 o C and the mixture was stirred at 0 o C for 45 min. The solution was then cooled to −45 o C and tert-butyl acetate (15 mL, 111.6 mmol, 4 equiv) was added. The resulting mixture was stirred for 1.5 h at −45 o C before a solution of 8 (9.7 g, 27.9 mmol, 1 equiv) in 50 mL of dry THF was added via cannula (rinsed with 25 mL). The reaction mixture was stirred at −45 o C for 22 h. The solution was then warmed to 0 o C before the reaction was quenched with 200 mL of saturated NH4Cl. The aqueous phase was extracted with EtOAc and the combined organic layers were washed with saturated NaHCO3 and brine. The organic phase was dried over MgSO4, filtered and concentrated under reduced pressure to afford the crude mixture which was purified by flash column chromatography (SiO2, petroleum ether/EtOAc: 92/8) to yield the desired compoud 9 (10.5 g, 87%) as a colorless oil. Rf (10) A degassed solution of 9 (100 mg, 0.23 mmol, 1 equiv) in EtOH (3.8 mL) was prepared in a reaction tube and the vessel was purged with argon. Solid catalyst [{RuCl((S)-Synphos)}2(μ-Cl)3][Me2NH2] (3.9 mg, 0.0023 mmol, 0.01 equiv) was then added and the reaction vessel was degassed by three vacuum-argon cycles and then placed under argon in a 250 mL stainless steel autoclave. The argon atmosphere was replaced with hydrogen by three cycles of pressurizing and the pressure adjusted to 100 bar. The autoclave was heated at 50 o C and stirring was maintained for 6 h. After cooling, the reaction mixture was concentrated under reduced pressure to afford the crude product which was purified by flash chromatography (SiO2, petroleum ether/iPr2O: 8/2) to afford the desired compound 10 (70 mg, 70%) as a colorless oil. Rf (cyclohexane/EtOAc: 9/1) 0. (13) . To a solution of 2 (137 mg, 0.25 mmol, 1 equiv) in dry THF (1.4 mL) was added BH3.Me2S (2M in THF, 0.25 mL, 0.75 mmol, 3 equiv) at 0 o C. The mixture was stirred at 0 o C for 1 h then allowed to rise to rt. NaOH 3M (1.25 mL, 3.75 mmol, 15 equiv) and 35% H2O2 in H2O (0.32 mL, 3.75 mmol, 15 equiv) were added at 0 o C and the resulting solution was stirred at rt for 1 h. Saturated NH4Cl was added and the aqueous phase was extracted with CH2Cl2. The combined organic layers were washed with saturated NH4Cl, dried over MgSO4, filtered and concentrated under reduced pressure. (14) . To a solution of 13 (107 mg, 0.19 mmol, 1 equiv) in dry THF (1.6 mL) were successively added triphenylphosphine (60 mg, 0.23 mmol, 1.2 equiv), 1-phenyl-1H-tetrazole-5-thiol (41 mg, 0.23 mmol, 1.2 equiv) and DIAD (0.12 mL, 0.23 mmol, 1.2 equiv) dropwise at rt. The mixture was stirred at rt for 22.5 h. Saturated NaHCO3 was added and the aqueous phase was extracted with EtOAc. The combined organic phases were washed with saturated NaHCO3, dried over MgSO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (SiO2, petroleum ether/iPr2O: 9/1 to petroleum ether/EtOAc: 9/1) to give 14 (109 mg, 80%) as a pale yellow oil. Rf (cyclohexane/EtOAc: 8/2, ninhydrin, UV) 0.63; 1 
tert-Butyl (4S,5R)-5-{(S)-2-[(tert-butyldimethylsilyl)oxy]-4-hydroxybutyl}-4-{(R)-1-[(tert-butyldimethylsilyl)oxy]ethyl}-2,2-dimethyloxazolidine-3-carboxylate
tert-Butyl (4S,5R)-5-{(R)-2-[(tert-butyldimethylsilyl)oxy]-4-{[(1-phenyl-1H-tetrazol-5-yl)thio]butyl}-4-{[(R)-1-(tert-butyldimethylsilyl)oxy]ethyl}-2,2-dimethyloxazolidine-3-carboxylate
tert-Butyl (4S,5R)-5-{(R)-2[(tert-butyldimethylsilyl)oxy]-4-[(1-phenyl-1H-tetrazol-5-yl)sulfonyl]butyl}-4-{(R)-1-[(tert-butyldimethylsilyl)oxy]ethyl}-2,2-dimethyloxazolidine-3-carboxylate (A')
. To a solution of 14 (95 mg, 0.13 mmol, 1 equiv) in dry CH2Cl2 (2 mL) were added NaHCO3 (33 mg, 0.39 mmol, 3 equiv) and m-CPBA (67 mg, 0.39 mmol, 3 equiv) at 0 o C. The mixture was stirred for 14 h at rt. Saturated Na2S2O3 was added at 0 o C and the mixture was diluted with CH2Cl2. The white solid was filtered and the aqueous layer was extracted with CH2Cl2. The combined organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (SiO2, pentane / iPr2O: 9/1 to 8/2) to give A' (67 mg, 68%) as a pale yellow oil. Rf (cyclohexane/EtOAc: 8/2, ninhydrin, UV) 0.58; 1 (15) . To a solution of (2S,3S,E)-2-((tert-butyldimethylsilyl)oxy)-5-iodo-3-methylhex-4-en-1-ol 19 (150 mg, 0.31 mmol, 1 equiv) in EtOH (70 mL) was added PPTS (7.8 mg, 0.03 mmol, 0.1 equiv) at rt. After 24 h at rt, the mixture was concentrated under reduced pressure. Purification by flash chromatography on silica gel (petroleum ether/Et2O = 100:0 to 80:20) afforded the alcohol 15 as a pale yellow oil (55 mg, 47%) and bis-protected alcohol was recovered (57 mg, 38%). tert-Butyl (4S,5R)-5-{(2S,4E,6R,7S,8E)-2,6-bis[(tert-butyldimethylsilyl)oxy]-9-iodo-7-methyldeca-4,8-dien-1-yl}-4-{(R)-1-[(tert-butyldimethylsilyl) oxy]ethyl}-2,2-dimethyloxazolidine-3-carboxylate (16) . To a solution of 15 (40 mg, 0.11 mmol, 1 equiv) in dry CH2Cl2 were added at rt MS 4Å (30 mg), TPAP (3 mg, 0.01 mmol, 0.08 [a] equiv) and NMO (15 mg, 0.13 mmol, 1.2 equiv). The mixture was stirred for 2 h at rt and filtered over a pad of celite (CH2Cl2). The crude aldehyde was used directly into the next step. To a solution of A (55 mg, 0.07 mmol, 1 equiv) in dry THF (1.5 mL) was added dropwise KHMDS (0.15 mL, 0.07 mmol, 0.5 M in toluene, 1.05 equiv) at -78 o C. The brown solution was stirred for 30 min at -78 o C before adding dropwise a solution of the crude aldehyde (40 mg, 0.11 mmol, 1.5 equiv) in THF (0.5 mL). The mixture was stirred 2 h at -78 o C then 1 h at rt. An aqueous solution of NH4Cl was added and the phases were separated. The aqueous layer was extracted twice with EtOAc. The combined organic layers were washed with water, dried over Na2SO4 and concentrated under reduced pressure. Purification by flash chromatography on silica gel (SiO2, pentane/Et2O: 100/0 to 95/5) afforded 16 as a colorless oil (50 mg, 76%, E/Z > 95:5, mixture of rotamers (21) . To a slurry of NaH (60% dispersion in oil, 7.0 g, 110 mmol, 1 equiv) in dry THF (300 mL) were added dropwise ethylene glycol 20 (28.8 mL, 510 mmol, 3 equiv), tetrabutylammonium iodide ( (18) . Dess-Martin periodinane (2.54 g, 6 mmol, 1.1 equiv) was added to a solution of alcohol 21 (1 g, 5.5 mmol, 1 equiv) in dry CH2Cl2 (30 mL) at 0 o C. After stirring 3 h at rt, the reaction was quenched with saturated NaHCO3 and the mixture was stirred vigorously until two clear layers were obtained. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were dried over MgSO4 and the solvent was removed under reduced pressure to a crude mixture which was purified by flash chromatography (SiO2, petroleum ether/EtOAc: 6/4) to give the alcohol 18 as a yellow oil (0.605 g, 61%). Rf (cyclohexane/EtOAc:4/6, KMnO4, UV) 0.59; 1 (19) . Glycine methyl ester hydrochloride 22 (7.28 g, 58 mmol, 1 equiv) was suspended in CH2Cl2 (200 mL) and Et3N (9 mL, 64 mmol, 1.1 equiv) was added at 0 o C. The mixture was stirred for 30 min at 0 o C and Boc2O (13.95 g, 64 mmol, 1.1 equiv) was added at rt. The reaction was stirred for 26 h at rt and H2O (150 mL) was added. The mixture was extracted with CH2Cl2 and the organic phase was washed with 100 mL of HCl (1 N), 100 mL of saturated Na2CO3 and 100 mL of brine. The organic layer was dried over MgSO4, filtered, and the solvent was removed under reduced pressure. Flash chromatography of the crude mixture (SiO2, petroleum ether/EtOAc: 7/3) gave the desired compound 19 as a colorless oil (10.59 D 20 [a] g, 97%). Rf (cyclohexane/EtOAc:1/1, KMnO4) 0.63; 1 H NMR (300 MHz, CDCl3) d 5.00 (bs, 1H), 3.92 (d, J 5.5 Hz, 2H), 3.75 (s, 3H), 1.45 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 170. 8, 155.7, 80.0, 52.2, 42.2, 28.3 . (17) . To a solution of diisopropylamine (11.6 mL, 82.5 mmol, 3.3 equiv) in THF (90 mL), was added dropwise at -78 o C, a 2.3 M solution of nBuLi in THF (33 mL, 75 mmol, 3 equiv). The solution was stirred for 30 min at -78 o C then transferred via cannula to a solution of 19 (4.7 g, 25 mmol, 1 equiv) and ZnCl2 (4.09 g, 30 mmol, 1.2 equiv) in dry THF (55 mL). The mixture was stirred 45 min at -78 o C and a solution of 18 (5.82 g, 32.3 mmol, 1.3 equiv) in dry THF (35 mL) was added via cannula. The resulting solution was stirred for 30 min at -78 o C before it was hydrolyzed with saturated NH4Cl and extracted with EtOAc. The combined organic layers were dried over MgSO4, the solvent was evaporated in vacuo, and the crude product was purified by flash chromatography (SiO2, petroleum ether/EtOAc: 6/4). The corresponding alcohol was obtained as a colorless oil (6.94 g, 75%). Dess-Martin periodinane (14.1 g, 27.2 mmol, 1.8 equiv) was added to a solution of this alcohol (6.70 g, 18.1 mmol, 1 equiv) in dry CH2Cl2 (160 mL) at 0 o C. After stirring 3.5 h at rt, the reaction was quenched with saturated NaHCO3 and the mixture was stirred vigorously until two clear layers were obtained. The layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were dried over MgSO4 and the solvent was removed under reduced pressure. The crude mixture was purified by flash chromatography (SiO2, cyclohexane/EtOAc: 8/2) to give the ketone 17 as a colorless oil (1.54 g, 23%). Rf placed in a reaction tube and the vessel was purged with argon. Anhydrous acetone (1.5 mL) previously degassed by three vacuum-argon cycles was added at rt. To this suspension was added dropwise methanolic HBr (47 µL, 0.009 equiv of a 0.19N solution prepared by adding 48% aqueous HBr in degassed methanol) and the suspension was stirred at room temperature for 30 min. The suspension immediately turned yellow, then an orange precipitate appeared and the solvent was thoroughly evaporated under vacuum to give the catalyst as an orange-brown solid [RuBr2((S)-Synphos)], which was used directly. A solution of β-ketoester hydrochloride 17 (150 mg, 0.41 mmol, 1 equiv) in degassed anhydrous CH2Cl2 (1.5 mL) was then added. The reaction vessel was degassed by three vacuum-argon cycles and then placed under argon in a 250 mL stainless steel autoclave. The argon atmosphere was replaced with hydrogen by three cycles of pressurizing and the pressure adjusted to 120 bar. The autoclave was heated at 50 o C and stirring was maintained for 96 h. After cooling, the reaction mixture was concentrated under reduced pressure to afford the crude β-hydroxy ester which was purified by flash chromatography (SiO2, cyclohexane/EtOAc: 6/4) to give syn-23 (110 mg, 73%) as a colorless oil. Rf (cyclohexane/AcOEt: (syn-24) . To a solution of syn-23 (97 mg, 0.26 mmol, 1 equiv) in dry DMF (0.5 mL) were added successively imidazole (54 mg, 0.79 mmol, 3 equiv) and TBSCl (99 mg, 0.66 mmol, 2.5 equiv) at rt. The mixture was stirred for 18 h at rt, then saturated aqueous NaCl and iPr2O were added. The aqueous phase was extracted with iPr2O. The combined organic layers were washed with brine, dried over MgSO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2, petroleum ether/EtOAc: 9/1) to give syn-24 (111 mg, 87%) as a colorless oil. Rf (cyclohexane/AcOEt: 7/3, ninhydrin, UV) 0.67; 1 (27) . To a suspension of LiAlH4 (287 mg, 7.56 mmol, 1.5 equiv) in Et2O (7.5 mL) was added dropwise a solution of 26 (1.05 g, 5.04 mmol, 1 equiv) in Et2O (7.5 mL) at 0 o C. The mixture was stirred for 1.5 h and 600 mg of SiO2 were added at 0 o C, followed by water (1 mL), an aqueous solution of 15% NaOH (3 mL) and water again (1 mL). MgSO4 was added, the mixture was filtered and the solvent was removed under reduced pressure to afford the desired product 27 (866 mg, 95%) as a colorless oil. Rf (cyclohexane/EtOAc: 8 (28) . To a solution of PPh3 (1.40 g, 5.33 mmol, 1.2 equiv) in CH2Cl2 (15 mL) cooled to 0 o C were successively added imidazole (453 mg, 6.66 mmol, 1.5 equiv) and I2 (1.52 g, 5.99 mmol, 1.35 equiv). A solution of 27 (800 mg, 4.44 mmol, 1 equiv) in CH2Cl2 (2.5 mL) was added and the mixture was stirred at room temperature for 2 h. The solvent was removed under reduced pressure and saturated aqueous Na2S2O3 was added. The aqueous layer was extracted with Et2O and the combined organic layers were washed with water and brine, dried over MgSO4 and concentrated under reduced pressure. Pentane was added, the suspension was filtered and the solvent was removed under reduced pressure. The crude mixture was purified by flash column chromatography (SiO2, petroleum ether/toluene: 83/7) to afford the desired product 28 ( mmol, 1.1 equiv) was added dropwise. The mixture was stirred at 0 o C for 10 min and a solution of 28 (484 mg, 1.67 mmol, 1.1 equiv) in THF (2.5 mL) was added dropwise. The mixture was stirred at room temperature for 23 h. A 10% aqueous solution of HCl (8 mL) and AcOEt (8 mL) were added and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over MgSO4 and concentrated under reduced pressure. The crude mixture was purified by flash column chromatography (SiO2, petroleum ether/EtOAc: 98/2 then 85/15) to afford the desired product 29 (238 mg, 56%) as a yellow oil. Rf (cyclohexane/EtOAc: 8/2, KMnO4) 0.40; (cyclohexane/AcOEt: 7/3, KMnO4) 0.68; : +11.5 (c 0.75, CHCl3); 1 H NMR (C6D6, 300 MHz) δ 7.34 -7.28 (m, 2H), 7.24 -7.06 (m, 3H), 4.33 (s, 2H), 4.25 -4.15 (m, 1H), 3.37 (s, 3H), 3.18 (dd, J 8.9, 6.0 Hz, 1H), 3.12 (dd, J 8.9, 6.2 Hz, 1H), 2.45 (dd, J 14.7, 7.7 Hz, 1H), 2.29 (dd, J 14.7, 4.8 Hz, 1H), 1.78 -1.62 (m, 1H, H7), 1.59 -1.40 (m, 3H), 1.22 -1.04 (m, 1H), 0.98 (s, 9H), 0.92 (d, J 6.7 Hz, 3H), 0.11 (s, 3H), 0.11 (s, 3H); 13 Methyl (3R,6S)-3,7 -dihydroxy-6-methylheptanoate (R,S)- (32) . To a solution of (R,S)-31 (138 mg, 0.35 mmol, 1 equiv) in THF (1.8 mL) was added palladium on carbon 10% (56 mg, 0.05 mmol, 0.15 equiv). The medium was purged with argon and three vaccum-H2 cycles were made. The mixture was stirred at room temperature for 22 h under 1 atm of H2, filtered on celite and concentrated under reduced pressure. The crude mixture was purified on silica gel column chromatography (petroleum ether/MTBE: 6/4) to afford the desired product (R,S)-32 (102 mg, 95%) as a colorless oil. Rf (cyclohexane/AcOEt: 7/3, KMnO4) 0.38;
(2S,3S)(E)-2-[(tert-Butyldimethylsilyl)oxy]-5-iodo-3-methylhex-4-en-1-ol
2-[(4-Methoxybenzyl)oxy]ethan-1-ol
2-[(4-Methoxybenzyl)oxy}acetaldehyde
Methyl 2-[(tert-butoxycarbonyl)amino]-4-[(4-methoxybenzyl)oxy]-3-oxobutanoate
Methyl (2R,3R)-2-[(tert-butoxycarbonyl)amino]-3-[(tert-butyldimethylsilyl)oxy]-4-[(4-methoxybenzyl)oxy]butanoate
: Methyl (3R,6S)-3-hydroxy-6-methyl-7-oxoheptanoate (R,S)- (33) . To a solution of (R,S)-32 (82 mg, 0.27 mmol, 1 equiv) in CH2Cl2 (1 mL) was added DMP (171 mg, 0.40 mmol, 1.5 equiv) and the mixture was stirred at room temperature for 3 h. After dilution with Et2O, the organic layer was successively washed with saturated aqueous Na2S2O3 and a saturated solution of NaHCO3. The aqueous layer was extracted with AcOEt, the combined organic layers were washed with brine, dried over MgSO4 and concentrated under reduced pressure. The crude mixture was purified by silica gel column chromatography (petroleum ether/iPr2O: 8/2) to afford the desired product (R,S)-33 (52 mg, 64%) as a colorless oil. Rf (cyclohexane/AcOEt: 6/4, KMnO4) 0.68; 1 (35) . To a solution of 34 (145 mg, 0.16 mmol, 1.4 equiv) and (S,S)-33 (36 mg, 0.12 mmol, 1 equiv) in freshly distilled DMSO (4.1 mL) were successively added CrCl2 (230 mg, 1.87 mmol, 16 equiv) and NiCl2(dppe) (3.8 mg, 0.007 mmol, 0.06 equiv). Three vacuum/argon cycles were performed and the mixture was stirred at 
